Capsaicin for Cerebral Perfusion Augmentation: A Randomized Open-Label Trial

HomeStrokeAhead of PrintCapsaicin for Cerebral Perfusion Augmentation: A Randomized Open-Label Trial No AccessLetterRequest AccessAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessLetterRequest AccessCapsaicin for Cerebral Perfusion Augmentation: A Randomized Open-Label Trial Juan Manuel Marquez-Romero, Claudio García-Perales, Maricela García-Arellano, María Soledad Ortíz, Carlos David Pérez-Malagón, María Raquel Huerta-Franco and Francisco Miguel Vargas-Luna Juan Manuel Marquez-RomeroJuan Manuel Marquez-Romero Correspondence to: Juan Manuel Marquez-Romero, MD, MSc, Neurology Department, HGZ 2, Instituto Mexicano del Seguro Social (IMSS), Av. de los Conos 102, Ojocaliente, Aguascalientes, Mexico 20190. Email E-mail Address: [email protected] https://orcid.org/0000-0002-5059-1174 Departamento de Neurología, HGZ 2, Instituto Mexicano del Seguro Social (IMSS), Aguascalientes, Mexico (J.M.M.-R., C.D.P.-M.). , Claudio García-PeralesClaudio García-Perales Departamento de Neurología, HGZ 50, Instituto Mexicano del Seguro Social (IMSS), San Luis Potosí, Mexico (C.G.-P.). , Maricela García-ArellanoMaricela García-Arellano Departmento de Terapia Intensiva Pediátrica, Centenario Hospital "Miguel Hidalgo," Aguascalientes, Mexico (M.G.-A., M.S.O.). , María Soledad OrtízMaría Soledad Ortíz Departmento de Terapia Intensiva Pediátrica, Centenario Hospital "Miguel Hidalgo," Aguascalientes, Mexico (M.G.-A., M.S.O.). , Carlos David Pérez-MalagónCarlos David Pérez-Malagón Departamento de Neurología, HGZ 2, Instituto Mexicano del Seguro Social (IMSS), Aguascalientes, Mexico (J.M.M.-R., C.D.P.-M.). , María Raquel Huerta-FrancoMaría Raquel Huerta-Franco https://orcid.org/0000-0001-7935-5151 Departamento de Ciencias Aplicadas al Trabajo, Universidad de Guanajuato, León, Mexico (M.R.H.-F.). and Francisco Miguel Vargas-LunaFrancisco Miguel Vargas-Luna https://orcid.org/0000-0003-2088-8492 Departamento de Ingeniería Física, Universidad de Guanajuato, León, Mexico (F.M.V.-L.). Originally published8 Mar 2024https://doi.org/10.1161/STROKEAHA.123.046045Stroke. 2024;0FootnotesFor Sources of Funding and Disclosures, see page XXX.Correspondence to: Juan Manuel Marquez-Romero, MD, MSc, Neurology Department, HGZ 2, Instituto Mexicano del Seguro Social (IMSS), Av. de los Conos 102, Ojocaliente, Aguascalientes, Mexico 20190. Email scint1st@gmail.com eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetails Advertisement Article InformationMetrics © 2024 American Heart Association, Inc.https://doi.org/10.1161/STROKEAHA.123.046045PMID: 38456262 Originally publishedMarch 8, 2024 Keywordscapsaicincerebrovascular circulationrisk factorsultrasonography, Doppler, transcranialPDF download Advertisement SubjectsClinical Studies